Nevertheless, some data now suggest that a daily administration of folic acid at a dose lower than 1 mg may be adequate to reverse hyperhomocysteinemia (Boushey et al, 1995
The split between weightloss and diabetes indications meant carriers and sponsors will need clear criteria on whether to restrict coverage to diabetes (and, if so, under what clinical rules), or to extend support to obesity and cardiometabolic risk reduction more broadly
Acta como el principal regulador del equilibrio redox intracelular, participa en la detoxificacin enzimtica de xenobiticos y es cofactor en procesos que mantienen la integridad de protenas, lpidos y ADN
There's no doubt that Roche is playing catchup in the category, one of a lengthening list of pharma companies that are hoping to hit on effective 'me-too' products that can make a dent in the substantial lead held by market leaders Novo Nordisk and Eli Lilly, which already have injectable GLP-1s for diabetes and obesity on the market